Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00511797
Status:
COMPLETED
Last Update Posted:
2017-01-26
First Post:
2007-08-03
Brief Title:
SH T00186 Phase II III Optimal Drospirenone DRSP Dose Finding and Placebo-controlled Comparative Study
Sponsor:
Bayer
Organization:
Bayer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07
Start Date Type:
None
Primary Completion Date:
2009-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-03
First Submit QC Date:
August 3 2007
Study First Post Date:
2007-08-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2010-10-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-30
Last Update Post Date:
2017-01-26
Last Update Post Date Type:
ESTIMATED